Skip to main content
Log in

Primary CNS lymphoma: 5-year survival in relation to dosage of methotrexate and radiation

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859–863

    CAS  PubMed  Google Scholar 

  2. Blay JY, Bouhour D, Carrie C, et al. (1995) The C5R protocol: a regimen of high dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin’s lymphoma of patients with no known cause of immunosuppression. Blood 86:2922–2929

    CAS  PubMed  Google Scholar 

  3. Meyer MA (2001) Neurotoxicity of chemotherapy agents. In: Perry M (ed) The chemotherapy sourcebook, 3rd edn. Lipincott, Williams, Wilkins, New York, pp 504–514

  4. Plasswilm L, Herrlinger U, Korfel A, Weller M, Kuker W, Kanz L, Thiel E, Bamberg M (2002) Primary central nervous system (CNS) lymphoma in immunocompetent patients. Ann Hematol 81:415–423

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Andrew Meyer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer, M.A. Primary CNS lymphoma: 5-year survival in relation to dosage of methotrexate and radiation. Ann Hematol 83, 549 (2004). https://doi.org/10.1007/s00277-003-0821-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-003-0821-z

Keywords

Navigation